Reply: Comment on The Necessity of Guidance: Optimizing Adjuvant Therapy for Stage II/III MSI-H Gastric Cancer Through the Interplay of Evidence, Clinical Judgment, and Patient Preferences

Author: In-Ho KIM ¹ ; Wonyoung CHOI ; Hye Sook HAN ;
Author Information

1. Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Publication Type:Letter to the Editor
From:Journal of Gastric Cancer 2024;24(4):353-355
CountryRepublic of Korea
Language:English